PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CAH | WEITZMAN DEBORAH | CEO, PSS Segment | Aug 18 '26 | Sale | 235.45 | 7,354 | 1,731,525 | 77,901 | Aug 20 |
| CAH | WEITZMAN DEBORAH | CEO, PSS Segment | Aug 20 '25 | Sale | 150.53 | 21,367 | 3,216,375 | 53,428 | Aug 20 |
| CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Nov 27 '23 | Option Exercise | 74.10 | 27,642 | 2,048,355 | 71,844 | Nov 29 |
| CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Nov 27 '23 | Sale | 106.31 | 36,642 | 3,895,411 | 35,202 | Nov 29 |
| CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Aug 28 '23 | Option Exercise | 71.43 | 6,712 | 479,438 | 50,914 | Aug 29 |
| CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Aug 28 '23 | Sale | 89.81 | 6,712 | 602,805 | 44,202 | Aug 29 |